Lifevantage Corp
LFVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000849146
In the last 90 days, Lifevantage Corp insiders filed 1 open-market purchase and 2 sales; 88 institutions reported holding it in 13F filings for Q2 2026, worth $36.9M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 17, 2026
- $60.6M
- Insider buysLast 90 days, $6.07K in total
- 1
- Insider sellsLast 90 days, $104.5K in total
- 2
- 13F holdersQ2 2026, −13 vs. previous quarter
- 88
- 13F valueReported value at the end of Q2 2026
- $36.9M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2026
- $182.6M
- −20.1% year over year
- Net income, FY2026
- $5.07M
- −48.3% year over year
- Free cash flow, FY2026
- $6.67M
- −36.5% year over year
- Revenue, Q1 FY2027
- $37.1M
- −22.0% year over year
Revenue flow, FY2026
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 906.6K
- Shares sold short
- Change
- −69.4K
- −7.1% vs. previous
- Days to cover
- 42.11
- At average daily volume
Superinvestors holding LFVN, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding LFVN at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Lifevantage Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 16, 2026 (view filing)4:05 PM ET | Nov 12 | 4 days | Beindorff Michael ADirector | SSale | −10.0K | $4.89 | −$48.9K | −24.0%31.6K after | |
| Sep 17, 2026 (view filing)4:05 PM ET | Sep 15 | 2 days | Lewis DarwinDirector | PPurchase | +976 | $6.22 | +$6.07K | +0.7%138.2K after | 10b5-1 |
| Sep 14, 2026 (view filing)6:55 PM ET | Sep 11-14 | 3 days | Cunningham KristenChief Sales Officer | SSale | −9.00K | $6.18 | −$55.6K | −7.0%120.2K after | 2 lots |
| Jun 17, 2026 (view filing) | Jun 15 | 2 days | Lewis DarwinDirector | PPurchase | +705 | $8.60 | +$6.06K | +0.5%137.3K after | 10b5-1 |
| Jun 5, 2026 (view filing) | Jun 3 | 2 days | Beindorff Michael ADirector | SSale | −10.0K | $8.55 | −$85.5K | −19.4%41.6K after | |
| Mar 18, 2026 (view filing) | Mar 16 | 2 days | Lewis DarwinDirector | PPurchase | +1.05K | $5.23 | +$5.52K | +0.8%136.6K after | 10b5-1 |
| Mar 2, 2026 (view filing) | Feb 26-Mar 2 | 4 days | Dayton JuddDirector | PPurchase | +33.2K | $4.59 | +$152.4K | +70.4%80.4K after | 3 lots |
| Feb 11, 2026 (view filing) | Feb 9 | 2 days | Lewis DarwinDirector | PPurchase | +3.96K | $5.22 | +$20.6K | +3.0%135.5K after | |
| Dec 17, 2025 (view filing) | Dec 15 | 2 days | Lewis DarwinDirector | PPurchase | +805 | $6.54 | +$5.26K | +0.6%131.6K after | 10b5-1 |
| Nov 21, 2025 (view filing) | Nov 19 | 2 days | Beindorff Michael ADirector | SSale | −12.6K | $6.42 | −$80.9K | −22.3%43.8K after |
Top 10 13F holders, Q2 2026
See all 88 holdersThe largest institutional positions in Lifevantage Corp at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Capital Management Corp | 1,878,411 | $11.7M | 1.76% | −563,508−23.1% | Reduced |
| Renaissance Technologies LLC | 669,418 | $4.18M | 0.01% | −198,286−22.9% | Reduced |
| Vanguard Capital Management LLC | 429,203 | $2.68M | 0.00% | −219−0.1% | Reduced |
| BlackRock, Inc. | 268,605 | $1.68M | 0.00% | −501,093−65.1% | Reduced |
| Dimensional Fund Advisors LP | 256,296 | $1.60M | 0.00% | −19,900−7.2% | Reduced |
| Envestnet Asset Management Inc | 229,907 | $1.43M | 0.00% | +10,745+4.9% | Added |
| Susquehanna International Group, LLP | 169,046 | $1.05M | 0.00% | +169,046 | New |
| American Century Companies Inc | 144,386 | $901.0K | 0.00% | +39,722+38.0% | Added |
| Jane Street Group, LLC | 138,056 | $861.5K | 0.00% | +138,056 | New |
| Geode Capital Management, LLC | 120,830 | $754.3K | 0.00% | −140,362−53.7% | Reduced |
Holders of 5% or more of LFVN
See all 2 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Lifevantage Corp.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Capital Management Corp | 13G/A | 18.30%2.31M shares | +3.40 ppfrom 14.90% | Apr 23, 20257 filings | Oct 22, 2026 | SEC |
| Renaissance Technologies LLC | 13G/A | 5.31%669.4K shares | – | Feb 11, 20215 filings | Aug 13, 2026 | SEC |